As of Oct 21
| +0.01 / +0.85%|
The 1 analysts offering 12-month price forecasts for Rxi Pharmaceuticals Corp have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +572.27% increase from the last price of 1.19.
The current consensus among 1 polled investment analysts is to Buy stock in Rxi Pharmaceuticals Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.